129 related articles for article (PubMed ID: 37981168)
21. Testicular Tumor Markers in the Spermatic Vein - Correlation to Pathology, Stage and Outcome.
Banner A; Lotterstätter M; Madersbacher S; Schauer I
Urology; 2021 Aug; 154():196-200. PubMed ID: 33878332
[TBL] [Abstract][Full Text] [Related]
22. Tumor markers and
Dondi F; Albano D; Bertagna F; Giubbini R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):287-292. PubMed ID: 34425969
[TBL] [Abstract][Full Text] [Related]
23. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
24. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
Favilla V; Russo GI; Spitaleri F; Urzì D; Garau M; Madonia M; Saita A; Pirozzi Farina F; La Vignera S; Condorelli R; Calogero AE; Cimino S; Morgia G
Int Urol Nephrol; 2014 Jun; 46(6):1131-5. PubMed ID: 24318367
[TBL] [Abstract][Full Text] [Related]
25. Predicting metastasized seminoma using gene expression.
Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
[TBL] [Abstract][Full Text] [Related]
26. Associations of preorchiectomy hormone levels to testicular germ cell tumor pathology, clinical stage, and size.
Pineault KG; Cheaib JG; Herati AS; Pierorazio PM
Asian J Androl; 2021; 23(2):224-226. PubMed ID: 32567579
[No Abstract] [Full Text] [Related]
27. [Testicular Cancer: Diagnostics, Therapy and Follow Up].
Kälin M; Mauti L; Pless M
Praxis (Bern 1994); 2016 May; 105(11):643-8. PubMed ID: 27223417
[TBL] [Abstract][Full Text] [Related]
28. Incidence of testicular carcinoma, therapy and quality assesment.
Junuzovic D; Mehmedbasic S; Mehmedbasic E; Spahovic A
Med Arh; 2011; 65(3):164-7. PubMed ID: 21776879
[TBL] [Abstract][Full Text] [Related]
29. Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?
Suzuki K; Nakazato H; Kurokawa K; Suzuki T; Suzuki K; Yamanaka H
Int Urol Nephrol; 1998; 30(5):593-8. PubMed ID: 9934803
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Miki T; Kamoi K; Fujimoto H; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Mikami K; Homma Y
Int J Urol; 2014 Aug; 21(8):S1-6. PubMed ID: 24725194
[TBL] [Abstract][Full Text] [Related]
31. [Testicular tumors--a current review].
Buse S; Lurati G; Schmid HP
Praxis (Bern 1994); 2003 Nov; 92(47):1989-97. PubMed ID: 14669500
[TBL] [Abstract][Full Text] [Related]
32. [Metachronous testicular seminoma with an interval of 14 years from the first nonseminomatous testicular tumor: a case report].
Kawasaki M; Satoh Y; Nakashima K; Nishimura K; Kaneko A; Udoh K; Fujiyama C; Uozumi J
Nihon Hinyokika Gakkai Zasshi; 2009 Jan; 100(1):16-21. PubMed ID: 19198225
[TBL] [Abstract][Full Text] [Related]
33. Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition.
Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
Hum Pathol; 2019 Dec; 94():16-22. PubMed ID: 31666197
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
[TBL] [Abstract][Full Text] [Related]
35. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
[TBL] [Abstract][Full Text] [Related]
36. Does Determining Tumor Markers from the Testicular Vein Enable Better Diagnosis and Prognosis?
Zauner T; Heidler S; Lusuardi L; Albrecht W; Wimpissinger F
Urol Int; 2021; 105(3-4):264-268. PubMed ID: 33333530
[TBL] [Abstract][Full Text] [Related]
37. Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series.
Dieckmann KP; Anheuser P; Simonsen H; Höflmayer D
Urol Int; 2017; 99(3):353-357. PubMed ID: 28668957
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
40. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
Mano R; Di Natale R; Sheinfeld J
Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
